These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 21557718
1. Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: a pilot study. Wagner M, Peterson CG, Stolt I, Sangfelt P, Agnarsdottir M, Lampinen M, Carlson M. Scand J Gastroenterol; 2011 Jul; 46(7-8):849-54. PubMed ID: 21557718 [Abstract] [Full Text] [Related]
2. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea. Wagner M, Sjöberg K, Vigren L, Olesen M, Benoni C, Toth E, Carlson M. Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205 [Abstract] [Full Text] [Related]
3. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel. Reimert CM, Tukahebwa EM, Kabatereine NB, Dunne DW, Vennervald BJ. Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822 [Abstract] [Full Text] [Related]
4. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease. Saitoh O, Kojima K, Sugi K, Matsuse R, Uchida K, Tabata K, Nakagawa K, Kayazawa M, Hirata I, Katsu K. Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313 [Abstract] [Full Text] [Related]
5. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Lettesjö H, Hansson T, Peterson C, Ung KA, Ringström G, Abrahamsson H, Simrén M. Scand J Gastroenterol; 2006 Jan; 41(1):54-9. PubMed ID: 16373277 [Abstract] [Full Text] [Related]
8. Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level. Peterson CG, Lampinen M, Hansson T, Lidén M, Hällgren R, Carlson M. Scand J Clin Lab Invest; 2016 Sep; 76(5):393-401. PubMed ID: 27223407 [Abstract] [Full Text] [Related]
9. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M. Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031 [Abstract] [Full Text] [Related]
11. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP. Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314 [Abstract] [Full Text] [Related]
12. Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD. Ling Lundström M, Peterson C, Hedin CRH, Bergemalm D, Lampinen M, Magnusson MK, Keita ÅV, Kruse R, Lindqvist CM, Repsilber D, D'Amato M, Hjortswang H, Strid H, BIOIBD Consortium, Söderholm JD, Öhman L, Venge P, Halfvarson J, Carlson M. Aliment Pharmacol Ther; 2024 Sep; 60(6):765-777. PubMed ID: 38997818 [Abstract] [Full Text] [Related]
13. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy. Scher H, Berman D, Weinberg EG, Schinkel M, Peper B, Chalton DO, Potter PC. Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698 [Abstract] [Full Text] [Related]
14. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. Pedersen B, Dahl R, Karlström R, Peterson CG, Venge P. Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596 [Abstract] [Full Text] [Related]
15. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed. Blom K, Rubin J, Halfvarson J, Törkvist L, Rönnblom A, Sangfelt P, Lördal M, Jönsson UB, Sjöqvist U, Håkansson LD, Venge P, Carlson M. World J Gastroenterol; 2012 Nov 28; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886 [Abstract] [Full Text] [Related]
17. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Carlson M, Raab Y, Peterson C, Hällgren R, Venge P. Am J Gastroenterol; 1999 Jul 28; 94(7):1876-83. PubMed ID: 10406252 [Abstract] [Full Text] [Related]